These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27438828)

  • 1. Non-Classical Inhibition of Carbonic Anhydrase.
    Lomelino CL; Supuran CT; McKenna R
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27438828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors drug design.
    McKenna R; Supuran CT
    Subcell Biochem; 2014; 75():291-323. PubMed ID: 24146385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How many carbonic anhydrase inhibition mechanisms exist?
    Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(3):345-60. PubMed ID: 26619898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II.
    Carta F; Vullo D; Maresca A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2182-5. PubMed ID: 22365761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.
    Oztürk Sarikaya SB; Topal F; Sentürk M; Gülçin I; Supuran CT
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4259-62. PubMed ID: 21669522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
    De Simone G; Supuran CT
    Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations.
    Carta F; Aggarwal M; Maresca A; Scozzafava A; McKenna R; Supuran CT
    Chem Commun (Camb); 2012 Feb; 48(13):1868-70. PubMed ID: 22218610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery.
    Nocentini A; Supuran CT
    Expert Opin Drug Discov; 2019 Nov; 14(11):1175-1197. PubMed ID: 31436118
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging role of carbonic anhydrase inhibitors.
    Supuran CT
    Clin Sci (Lond); 2021 May; 135(10):1233-1249. PubMed ID: 34013961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II.
    Alp C; Maresca A; Alp NA; Gültekin MS; Ekinci D; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):294-8. PubMed ID: 22380772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).
    Lomelino C; McKenna R
    Expert Opin Ther Pat; 2016 Aug; 26(8):947-56. PubMed ID: 27387065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
    Winum JY; Cecchi A; Montero JL; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3302-6. PubMed ID: 15908201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors.
    Supuran CT
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3467-74. PubMed ID: 20529676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
    Mishra CB; Tiwari M; Supuran CT
    Med Res Rev; 2020 Nov; 40(6):2485-2565. PubMed ID: 32691504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer.
    Winum JY; Colinas PA; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1419-26. PubMed ID: 23199483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.
    Nocentini A; Angeli A; Carta F; Winum JY; Zalubovskis R; Carradori S; Capasso C; Donald WA; Supuran CT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):561-580. PubMed ID: 33615947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
    Maresca A; Supuran CT
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4511-4. PubMed ID: 20580555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibition and the management of neuropathic pain.
    Supuran CT
    Expert Rev Neurother; 2016 Aug; 16(8):961-8. PubMed ID: 27211329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.